MedTrace Logo

Heart Rate Variability After Ablation

NCT06276296 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-02-23

No results posted yet for this study

Summary

Pulsed-field catheter ablation is a promising new treatment method for patients with atrial fibrillation. The mechanism of cell damage here is different from that of classic catheter ablation, in which the ganglion plexuses around the pulmonary veins are also damaged and thus changes in the autonomic nervous system occur. The aim of the work is to find out, using heart rate variability, whether the autonomic system is less affected during pulsed field ablation than in classic radiofrequency ablation.

Conditions

Interventions

DIAGNOSTIC_TEST

Holter EKG - 1 day before ablation

24 hours Holter EKG - 1 day before ablation

PROCEDURE

Radiofrequency ablation

Pulmonary vein isolation using radiofrequency ablation

PROCEDURE

Pulsed field ablation

Pulmonary vein isolation using pulsed field ablation

DIAGNOSTIC_TEST

Holter EKG - 1 month after ablation

24 hours Holter EKG 1 month after ablation

Sponsors & Collaborators

  • Vascular surgery, University hospital Královské Vinohrady, Prague

    collaborator OTHER

  • Charles University, Czech Republic

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-08-31
Completion
2024-10-01

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06276296 on ClinicalTrials.gov